EODData

MEMBERSHIP REGISTER LOG IN

FRA, EYWN: bioMérieux S.A

07 Nov 2025
LAST:

105.1

CHANGE:
 2.60		OPEN:
105.1		HIGH:
105.1		ASK:
0.0		VOLUME:
100
CHG(%):
2.41		PREV:
107.7		LOW:
105.1		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 25105.1105.1105.1105.1100
06 Nov 25107.7107.7107.7107.7100
05 Nov 25107.7107.7107.7107.7100
04 Nov 25104.2109.0104.2109.0100
31 Oct 25110.3110.3110.3110.310
30 Oct 25111.7111.7111.7111.710
29 Oct 25113.1113.1113.1113.110
28 Oct 25112.6112.6112.6112.610
27 Oct 25113.1113.1113.1113.110
24 Oct 25113.5113.5113.5113.510

COMPANY PROFILE

Name:bioMérieux S.A
About:bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDAS, a specific marker of severe bacterial infections/sepsis. It also develops Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. It has partnership with Boehringer Ingelheim and Evotec. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Sector:Healthcare
Address:376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Website:https://www.biomerieux.com
ISIN:FR0013280286
LEI:549300AK8Y0LBIQ4T071

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:35.11 
Forward P/E:24.81 
Price to Sales:3.23 
Price to Book:3.34 
Profit Margin:0.09 
Operating Margin:0.17 
Return on Assets:0.08 
Return on Equity:0.09 
DivYield:0.01 
Div/Share:0.90 
Revenue:4.122B 
EBITDA:943.1M 
Shares:117.93M 
Market Cap:12.394B 

TECHNICAL INDICATORS

MA5:107.962.7%
MA10:110.385.0%
MA20:110.595.2%
MA50:113.207.7%
MA100:117.6712.0%
MA200:116.7511.1%
RSI14:37.65 
WPR14:-100.00 
MTM14:-5.00
ROC14:-0.05 
ATR:1.50 
Week High:110.304.9%
Week Low:104.200.9%
Month High:115.009.4%
Month Low:104.2011.1%
Year High:130.6024.3%
Year Low:95.899.6%
Volatility:13.61 

RECENT SPLITS

Date Ratio
20 Sep 20173-1

RECENT DIVIDENDS

Date Amount
09 Jun 2025$0.90
07 Jun 2024$0.85
06 Jun 2023$0.85
06 Jun 2022$0.85
04 Jun 2021$0.62
14 Jul 2020$0.19
02 Jun 2020$0.33
04 Jun 2019$0.35
05 Jun 2018$0.34
06 Jun 2017$0.11